PPARG and lung cancer: These authors further demonstrated that transgenic miceover-expressing PPARγ exhibited reduced COX-2 in type II alveolar epithelialcells of lung, and those mice were protected against lung cancer development ina chemical carcinogenesis mouse model [38].